Through the partnership agreement, Mylan will commercialize Lupin's proposed etanercept biosimilar in Europe, Australia, New Zealand, Latin America, Africa and most markets throughout Asia, company said in release.
Enbrel is a TNF-inhibitoriindicated to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis and ankylosing spondylitis, it added.
For more information
Call us ✆ +91 9111-179961 or Visit Dollar
Advisory
No comments:
Post a Comment